283 related articles for article (PubMed ID: 20226822)
1. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
[TBL] [Abstract][Full Text] [Related]
2. Anti-VCAM-1 and anti-E-selectin SAINT-O-Somes for selective delivery of siRNA into inflammation-activated primary endothelial cells.
Kowalski PS; Lintermans LL; Morselt HW; Leus NG; Ruiters MH; Molema G; Kamps JA
Mol Pharm; 2013 Aug; 10(8):3033-44. PubMed ID: 23819446
[TBL] [Abstract][Full Text] [Related]
3. Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo.
Kowalski PS; Zwiers PJ; Morselt HW; Kuldo JM; Leus NG; Ruiters MH; Molema G; Kamps JA
J Control Release; 2014 Feb; 176():64-75. PubMed ID: 24389338
[TBL] [Abstract][Full Text] [Related]
4. Effective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexes.
Leus NG; Talman EG; Ramana P; Kowalski PS; Woudenberg-Vrenken TE; Ruiters MH; Molema G; Kamps JA
Int J Pharm; 2014 Jan; 459(1-2):40-50. PubMed ID: 24239833
[TBL] [Abstract][Full Text] [Related]
5. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
6. SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells.
Kowalski PS; Kuninty PR; Bijlsma KT; Stuart MC; Leus NG; Ruiters MH; Molema G; Kamps JA
Eur J Pharm Biopharm; 2015 Jan; 89():40-7. PubMed ID: 25460585
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-targeted delivery of dexamethasone by anti-VCAM-1 SAINT-O-Somes in mouse endotoxemia.
Li R; Kowalski PS; Morselt HWM; Schepel I; Jongman RM; Aslan A; Ruiters MHJ; Zijlstra JG; Molema G; van Meurs M; Kamps JAAM
PLoS One; 2018; 13(5):e0196976. PubMed ID: 29763440
[TBL] [Abstract][Full Text] [Related]
8. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
9. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
[TBL] [Abstract][Full Text] [Related]
11. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
12. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
13. VCAM-1 specific PEGylated SAINT-based lipoplexes deliver siRNA to activated endothelium in vivo but do not attenuate target gene expression.
Leus NG; Morselt HW; Zwiers PJ; Kowalski PS; Ruiters MH; Molema G; Kamps JA
Int J Pharm; 2014 Jul; 469(1):121-31. PubMed ID: 24746643
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes.
Asgeirsdóttir SA; Zwiers PJ; Morselt HW; Moorlag HE; Bakker HI; Heeringa P; Kok JW; Kallenberg CG; Molema G; Kamps JA
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F554-61. PubMed ID: 18160627
[TBL] [Abstract][Full Text] [Related]
15. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue.
Hossen MN; Kajimoto K; Akita H; Hyodo M; Ishitsuka T; Harashima H
J Control Release; 2010 Oct; 147(2):261-8. PubMed ID: 20647023
[TBL] [Abstract][Full Text] [Related]
16. MC3/SAINT-O-Somes, a novel liposomal delivery system for efficient and safe delivery of siRNA into endothelial cells.
He Y; Barlag M; Plantinga JA; Molema G; Kamps JAAM
J Liposome Res; 2023 Dec; 33(4):328-337. PubMed ID: 36920318
[TBL] [Abstract][Full Text] [Related]
17. Serum insensitive, intranuclear protein delivery by the multipurpose cationic lipid SAINT-2.
van der Gun BT; Monami A; Laarmann S; Raskó T; Slaska-Kiss K; Weinhold E; Wasserkort R; de Leij LF; Ruiters MH; Kiss A; McLaughlin PM
J Control Release; 2007 Nov; 123(3):228-38. PubMed ID: 17884225
[TBL] [Abstract][Full Text] [Related]
18. Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release.
Kunisawa J; Masuda T; Katayama K; Yoshikawa T; Tsutsumi Y; Akashi M; Mayumi T; Nakagawa S
J Control Release; 2005 Jul; 105(3):344-53. PubMed ID: 15936842
[TBL] [Abstract][Full Text] [Related]
19. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
20. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
